Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Yutaro Wada"'
Autor:
Yasuo Oguma, Makoto Hosono, Kaoru Okajima, Eri Inoue, Kiyoshi Nakamatsu, Hiroshi Doi, Tomohiro Matsuura, Masahiro Inada, Takuya Uehara, Yutaro Wada, Aritoshi Ri, Yutaka Yamamoto, Kazuhiro Yoshimura, Hirotsugu Uemura, Yasumasa Nishimura
Publikováno v:
Radiation, Vol 2, Iss 3, Pp 273-284 (2022)
The optimal sequence and combination of radium-223 therapy (Ra-223) for castration-resistant prostate cancer with bone metastasis (mCRPC) remain unclear. This study aimed to explore the prognostic factors after Ra-223 administration and to determine
Externí odkaz:
https://doaj.org/article/67ef6462d7574b8b954161441263d4db
Autor:
Yutaro Wada, Hajime Monzen, Mikoto Tamura, Masakazu Otsuka, Masahiro Inada, Kazuki Ishikawa, Hiroshi Doi, Kiyoshi Nakamatsu, Yasumasa Nishimura
Publikováno v:
Journal of Medical Physics, Vol 46, Iss 1, Pp 7-15 (2021)
Purpose: We investigated the performance of the simplified knowledge-based plans (KBPs) in stereotactic body radiotherapy (SBRT) with volumetric-modulated arc therapy (VMAT) for lung cancer. Materials and Methods: For 50 cases who underwent SBRT, onl
Externí odkaz:
https://doaj.org/article/706f639f6f544d749f380b1d643d2d7e
Autor:
Takaya Inagaki, Hiroshi Doi, Masahiro Inada, Naoko Ishida, Aritoshi Ri, Saori Tatsuno, Yutaro Wada, Takuya Uehara, Kiyoshi Nakamatsu, Makoto Hosono, Yasumasa Nishimura
Publikováno v:
Strahlentherapie und Onkologie. 199:465-476
Stereotactic body radiotherapy (SBRT) is a treatment option for early-stage lung cancer. We aimed to examine the differences in failure patterns after SBRT according to the clinical T stage.A total of 120 patients with early-stage lung cancer (T1-3N0
Autor:
Yutaro Wada, Hajime Monzen, Naoko Ishida, Aritoshi Ri, Saori Tatsuno, Takuya Uehara, Masahiro Inada, Hiroshi Doi, Kiyoshi Nakamatsu, Makoto Hosono, Yasumasa Nishimura
Publikováno v:
Medical Dosimetry.
Autor:
Y. Oguma, Hisato Kawakami, Hiroshi Doi, Yutaro Wada, Makoto Hosono, Saori Tatsuno, Kiyoshi Nakamatsu, Kazuki Ishikawa, Takuya Uehara, Masahiro Inada, Yasumasa Nishimura
Publikováno v:
Head & Neck
Background The present study aimed to evaluate the prognostic factors in human papillomavirus (HPV)‐positive and HPV‐negative oropharyngeal cancer (OPC) treated with definitive radiotherapy. Methods We retrospectively evaluated 101 patients with
Publikováno v:
International Journal of Fluid Machinery and Systems. 12:380-387
Autor:
Hiroshi Doi, Masakazu Otsuka, Kiyoshi Nakamatsu, Yutaro Wada, Yasumasa Nishimura, Hajime Monzen
Publikováno v:
Medical dosimetry : official journal of the American Association of Medical Dosimetrists. 47(1)
We investigated differences in the volumetric-modulated arc therapy (VMAT) dose distribution in prostate cancer patients treated by rectal gas removal and/or adaptive replanning. Cone-beam computed tomography (CBCT) scans were performed daily for 22
Autor:
Y. Oguma, Yutaro Wada, Kiyoshi Nakamatsu, Kazuki Ishikawa, Makoto Hosono, S. Tatsuno, Masahiro Inada, Takuya Uehara, Yasumasa Nishimura, Hiroshi Doi
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:e397-e398
PURPOSE/OBJECTIVE(S) The present study aimed to evaluate prognostic factors, particularly with respect to their role in establishing distinct prognostic subsets of human papillomavirus (HPV)-positive and -negative oropharyngeal cancer (OPC). MATERIAL
Autor:
Kazuki Ishikawa, Y. Oguma, Kiyoshi Nakamatsu, Hiroshi Doi, Yasumasa Nishimura, Masahiro Inada, Takuya Uehara, Yutaro Wada
Publikováno v:
Esophagus : official journal of the Japan Esophageal Society. 18(3)
The role of intensity-modulated radiation therapy in the treatment of cervical esophageal cancer remains unclear. The outcome of concurrent chemoradiotherapy for cervical esophageal squamous cell carcinoma using intensity-modulated radiation therapy
Autor:
Takaya Inagaki, Hiroshi Doi, Naoko Ishida, Aritoshi Ri, Saori Tatsuno, Yutaro Wada, Takuya Uehara, Masahiro Inada, Kiyoshi Nakamatsu, Makoto Hosono, Yasumasa Nishimura
Publikováno v:
Cancers; Volume 14; Issue 4; Pages: 933
Stereotactic body radiotherapy (SBRT) is a treatment option for early-stage lung cancer. The purpose of this study was to investigate the optimal dose distribution and prognostic factors for local control (LC) after SBRT for lung cancer. A total of 1